The ESOP Allotment Committee of Bliss GVS Pharma Limited approved the allotment of 55,250 equity shares of face value Re. 1/- each to eligible employees under the Bliss GVS Pharma Limited–Employee Stock Option Plan 2019 (Bliss GVS ESOP-2019) on September 04, 2026.

Key Details:

  • Total shares allotted: 55,250 equity shares
  • Face value: Re. 1/- per share
  • Exercise price: Rs. 43/- per share
  • Premium per share: Rs. 42/- per share
  • Distinctive numbers: 10,62,75,223 to 10,63,30,472 (both inclusive)
  • ISIN Number: INE416D01022
  • Shares rank pari-passu with existing equity shares of the Company

Change in Paid-up Share Capital:

  • Before allotment: 10,62,75,223 equity shares aggregating Rs. 10,62,75,223/-
  • After allotment: 10,63,30,472 equity shares aggregating Rs. 10,63,30,472/-

Regulatory Compliance:

  • Compliance with Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
  • Original ESOP plan filed with stock exchanges on 14/02/2020
  • BSE Application No: 106063
  • NSE Application No: 23188
  • BSE In-Principle Approval: DCS/FL/DS/ESOP-IP/542/2019-20 dated February 27, 2020
  • NSE In-Principle Approval: NSE/LIST/23188 dated March 04, 2020

Lock-in Details:

  • Lock-in period: 6 months from date of allotment
  • Lock-in expiry date: March 03, 2027

Additional Information:

  • Shares are in dematerialized form
  • No share certificate numbers applicable
  • No listing fees payable
  • Company Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072

Additional Announcements:

The filing does not contain any additional corporate updates beyond the ESOP allotment details.